Bristol receives subpoena over Abilify marketing

02/20/2012 | Wall Street Journal, The

The U.S. Attorney's Office for the Southern District of New York subpoenaed Bristol-Myers Squibb in an investigation of the company's marketing practices for antipsychotic Abilify, according to a company filing with the Securities and Exchange Commission.

View Full Article in:

Wall Street Journal, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX